Applied Clinical Trials
Case study shows that site activation is a key driver in determining patient enrollment cycle time, which can be minimized by identifying the "sweet spot" of sites to deploy for a clinical trial.
Valerie Legagneur
Advertisement
Articles by Valerie Legagneur
Applied Clinical Trials
Case study demonstrates that site activation is a key driver in determining patient enrollment cycle time.
Advertisement
Latest Updated Articles
Enrollment Cycle Times Can and Should Be OptimizedJanuary 17th 2018
- Enrollment Cycle Times Can and Should Be Optimized
January 17th 2018
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The 10 Most Powerful Study KRIs in RBQM and GCP Issues They Can Prevent
2
Comparing OpenAI and Mistral on Clinical Trial Matching
3
From Complexity to Endpoint Meaningfulness: Addressing Key Neuroscience Trial Challenges with eCOA
4
De-Risking FIH: Integrated Strategies for Rapid Proof-of-Concept (Sept 2026)
5